Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Reckitt Benckiser shares rebound, baby formula crisis lingers

Reckitt Benckiser shares rise after a baby formula verdict left the consumer giant’s shares at a decade low.

Video poster image

Reckitt says it will challenge the verdict, but as IGTV's Angeline Ong explains, there are concerns the recent ruling opens the door to more financial liabilities for the UK-listed company.

(AI Video Summary)

Reckitt Benckiser's share price slightly recovers after significant drop

The shares of Reckitt Benckiser recently went through a rough patch, sinking to their lowest point in 11 years. This drop happened because a jury gave a woman $60 million in damages, claiming the company's Enfamil formula caused her premature baby's death. It's a huge deal because this is just the start of many court cases, and the outcome will decide the company's fate.

While the stock has seen a bit of recovery since then, we can't forget the big dip it took on 28 February. On that day, Reckitt missed court and lowered their sales expectations due to not reporting all their debts in the Middle East. These challenges have really set the company back in a short amount of time.

The future of Reckitt?

The future for Reckitt is very uncertain right now. If they can successfully resolve the Enfamil case and do well in the upcoming trials, their stock may bounce back. But until we know what exactly will happen, we can't be sure about a short-term rebound. Investors are eagerly waiting to hear more about the legal troubles the company is facing.

The Enfamil case is especially important because it sets the stage for what will happen in future trials. Investors are keeping a close eye on how the company handles and resolves this case because it will show how well they can handle future legal battles. The fact that the stock is recovering a bit shows that some shareholders have confidence.

But, for Reckitt Benckiser to really move forward, they need to put this case behind them and deal with the problems they're facing. This will have a big impact on how the market sees the company and, ultimately, the stock price.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.